Sublingual immunotherapy (allergy drops) has long been the allergy treatment of choice throughout most of Western Europe. In their report to the May-June 2000 Allergy and Asthma Proceedings, the World Health Organization called allergy drops "a viable alternative to injections."

In 2000, Dr. Michael Morris traveled throughout the United States researching the application of sublingual immunotherapy and gathering the best current methodology from leading allergy centers. These concepts helped to inform the development of our current Allerdrops program, an alternative for allergy patients who are either unable to tolerate injections or have experienced only limited success with them. Dr. Morris has since helped hundreds of patients reclaim their lives from allergies with the aid of Allerdrops.

Dr. Morris provides environmental allergy management as part of his comprehensive Ear, Nose and Throat (Otolaryngology) practice in Washington, DC. He spent nearly a decade at Georgetown University advancing the field of Otolaryngology through teaching and research. And he has built a proud legacy of innovation that includes not only Allerdrops, but also a patented redesign of the tubes used to treat childhood ear disease-the most common device used in surgery today.